1 / 13

Global Allergic Conjunctivitis Market Growth

Allergic Conjunctivitis Market will exceed US$ 2 Billion mark by 2025. Allergic conjunctivitis unusually caused when a personu2019s eye comes in contact with an allergen (substances that cause allergies, like pollen, chemicals, dirt or mold spores) as the conjunctiva is prone to irritation from allergens. The eye becomes inflamed and sore. In conjunctivitis, the tissue (conjunctiva) that lines inside of the eyelid and the white of the eyeball that keeps the eyeball and eyelid moist became inflamed.<br>For More Information: <br>https://www.renub.com/allergic-conjunctivitis-market-p.php

renubresearch
Download Presentation

Global Allergic Conjunctivitis Market Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Allergic Conjunctivitis Market

  2. Report Description and Highlights Analyst View: According to Renub Research analysis the Allergic Conjunctivitis Market will exceed US$ 2 Billion mark by the end of year 2025. Allergic conjunctivitis unusually caused when a person’s eye comes in contact with an allergen (substances that cause allergies, like pollen, chemicals, dirt or mold spores) as the conjunctiva is prone to irritation from allergens. The eye becomes inflamed and sore. In conjunctivitis, the tissue (conjunctiva) that lines inside of the eyelid and the white of the eyeball that keeps the eyeball and eyelid moist became inflamed.  Conjunctivitis is one of the most common and treatable eye conditions. There are two types of conjunctivitis namely allergic and infective conjunctivitis. Further, allergic conjunctivitis is classified as acute and chronic conjunctivitis. Acute conjunctivitis is a short term condition and can cause generally during allergy season while chronic conjunctivitis can occur year-round and has a milder response to allergens. Common symptoms of chronic conjunctivitis include same as acute conjunctivitis i.e. burning and itching of the eyes and light sensitivity but it comes and goes more frequently.

  3. Global Allergic Conjunctivitis Market Allergic conjunctivitis is different from infective conjunctivitis as the cause is different. Allergic conjunctivitis is not contagious like the infective one. So it is vital to know whether the affected person have allergic or infective conjunctivitis since treatment for each condition is different. In the latest Renub Research report, Allergic Conjunctivitis Market, the report offers an in-depth primer of its upcoming market including how the allergic conjunctivitis market has grown and what it holds for the future, along with the key factors that are driving the market growth and challenges which are restraining the market growth. Irrespective of age, one who is susceptible to allergens, are more likely to develop allergic conjunctivitis, mostly the children and young adults. According to the Asthma and Allergy Foundation of America, allergies affect nearly 30 percent of adults and 40 percent of children and often run in families. If anyone who have allergies and live in locations with high pollen counts, they are more prone to allergic conjunctivitis. Read more here: https://www.renub.com/allergic-conjunctivitis-market-p.php

  4. Global – Forecast for Allergic Conjunctivitis Disease Type Market Share 2019 – 2025 Global Forecast for Allergic Conjunctivitis Disease Type Market Share (%) Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report

  5. Global Allergic Conjunctivitis Market Summary • Market Summary • Patient Population wise, China dominates the global allergic conjunctivitis patient population. The report provides patient population & population share for following countries: India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. • Country wise market, United States is the leading country in the global allergic conjunctivitis market. This research report covers following market and market share of following countries: India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain.  • Disease type: SAC and PAC holds largest market share This research report covers following diseases market and market share: Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) And Giant Papillary Conjunctivitis (GPC). • Drugs Profile and Pipe Line covered in the report are, Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266 and SYL-116011 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.  • Company-wise the report provides overview, initiatives and financial insights of Santen Pharmaceutical, Alcon (Novartis), Portola Pharmaceuticals and Ocular Therapeutix. • Request a free sample copy of the report: • https://www.renub.com/request-sample-page.php?gturl=allergic-conjunctivitis-market-p.php

  6. Global Allergic Conjunctivitis Market by Countries Allergic Conjunctivitis Market by Countries, 2019 – 2025 Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report

  7. Key Topics Covered in Allergic Conjunctivitis Market    Executive Summary 2.    Global Allergic Conjunctivitis Market and Patients Analysis 2.1    Allergic Conjunctivitis Market2.2    Allergic Conjunctivitis Patient Numbers2.3    Allergic Conjunctivitis Treated Patient Numbers 3.    Share Analysis – Global Allergic Conjunctivitis 3.1    Country Market Share3.2    Patients Population Share3.3    Treated Patients Population Share3.4    By Disease Type Share 4.    India 4.1    Allergic Conjunctivitis Patient Numbers4.2    Allergic Conjunctivitis Treated Patient Numbers4.3    Allergic Conjunctivitis Market

  8. Key Topics Covered in Allergic Conjunctivitis Market 5.    China 5.1    Allergic Conjunctivitis Patient Numbers5.2    Allergic Conjunctivitis Treated Patient Numbers5.3    Allergic Conjunctivitis Market 6.    Japan 6.1    Allergic Conjunctivitis Patient Numbers6.2    Allergic Conjunctivitis Treated Patient Numbers6.3    Allergic Conjunctivitis Market 7.    United States 7.1    Allergic Conjunctivitis Patient Numbers7.2    Allergic Conjunctivitis Treated Patient Numbers7.3    Allergic Conjunctivitis Market

  9. Key Topics Covered in Allergic Conjunctivitis Market 8.    United Kingdom 8.1    Allergic Conjunctivitis Patient Numbers8.2    Allergic Conjunctivitis Treated Patient Numbers8.3    Allergic Conjunctivitis Market 9.    France 9.1    Allergic Conjunctivitis Patient Numbers9.2    Allergic Conjunctivitis Treated Patient Numbers9.3    Allergic Conjunctivitis Market 10.    Germany 10.1    Allergic Conjunctivitis Patient Numbers10.2    Allergic Conjunctivitis Treated Patient Numbers10.3    Allergic Conjunctivitis Market

  10. Key Topics Covered in Allergic Conjunctivitis Market 11.    Italy 11.1    Allergic Conjunctivitis Patient Numbers11.2    Allergic Conjunctivitis Treated Patient Numbers11.3    Allergic Conjunctivitis Market 12.    Spain 12.1    Allergic Conjunctivitis Patient Numbers12.2    Allergic Conjunctivitis Treated Patient Numbers12.3    Allergic Conjunctivitis Market 13.    Disease Type – Global Allergic Conjunctivitis Market 13.1    Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)13.2    Vernal Keratoconjunctivitis (VKC)13.3    Atopic Keratoconjunctivitis (AKC)13.4    Giant Papillary Conjunctivitis (GPC)

  11. Key Topics Covered in Allergic Conjunctivitis Market 14.    Global Allergic Conjunctivitis Drugs Profile/Pipe Line Drugs 14.1    Zerviate 14.2    OTX-DP (Dexamethasone Insert) 14.3    ADX-10214.4    PRT2761 14.5    CVXL-0074 14.6    AK-00214.7    Bertilimumab 14.8    Reproxalap 14.9    ST-26614.10    SYL-116011 15.    Growth Driver 15.1    Rapid Urbanization and Growth of Particulate Pollution15.2    Increasing Ageing Population & Widespread Use of Medications for Various Eye Diseases 16.    Challenges 16.1    Diagnostic Challenges16.2    Undertreated by Patients

  12. Key Topics Covered in Allergic Conjunctivitis Market 17.    Santen Pharmaceutical 17.1    Company Overview 17.2    Initiatives 17.3    Financial Insight 18.    Alcon Inc. (Novartis) 18.1    Company Overview 18.2    Initiatives 18.3    Financial Insight 19.    Portola Pharmaceuticals Inc. 19.1    Company Overview 19.2    Initiatives 19.3    Financial Insight 20.    Ocular Therapeutix Inc. 20.1    Company Overview 20.2    Initiatives 20.3    Financial Insight If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com

  13. Global Allergic Conjunctivitis Market • Browse Related Report : • Epilepsy Drugs Market • Global Vitiligo Market • Contact Us • Tel: +1-678-302-0700 (US), • +91-120-421-9822 (INDIA) • Email: info@renub.com

More Related